1. Home
  2. CTXR vs ICCH Comparison

CTXR vs ICCH Comparison

Compare CTXR & ICCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • ICCH
  • Stock Information
  • Founded
  • CTXR 2007
  • ICCH 1950
  • Country
  • CTXR United States
  • ICCH United States
  • Employees
  • CTXR N/A
  • ICCH N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • ICCH Property-Casualty Insurers
  • Sector
  • CTXR Health Care
  • ICCH Finance
  • Exchange
  • CTXR Nasdaq
  • ICCH Nasdaq
  • Market Cap
  • CTXR 84.9M
  • ICCH 68.6M
  • IPO Year
  • CTXR N/A
  • ICCH 2017
  • Fundamental
  • Price
  • CTXR $2.65
  • ICCH $23.32
  • Analyst Decision
  • CTXR Buy
  • ICCH
  • Analyst Count
  • CTXR 2
  • ICCH 0
  • Target Price
  • CTXR $100.00
  • ICCH N/A
  • AVG Volume (30 Days)
  • CTXR 561.0K
  • ICCH 5.4K
  • Earning Date
  • CTXR 02-12-2025
  • ICCH 11-04-2024
  • Dividend Yield
  • CTXR N/A
  • ICCH N/A
  • EPS Growth
  • CTXR N/A
  • ICCH 42.86
  • EPS
  • CTXR N/A
  • ICCH 2.16
  • Revenue
  • CTXR N/A
  • ICCH $92,541,259.00
  • Revenue This Year
  • CTXR N/A
  • ICCH N/A
  • Revenue Next Year
  • CTXR N/A
  • ICCH N/A
  • P/E Ratio
  • CTXR N/A
  • ICCH $10.81
  • Revenue Growth
  • CTXR N/A
  • ICCH 14.09
  • 52 Week Low
  • CTXR $2.44
  • ICCH $14.78
  • 52 Week High
  • CTXR $26.75
  • ICCH $23.39
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 30.59
  • ICCH 59.38
  • Support Level
  • CTXR $2.44
  • ICCH $23.21
  • Resistance Level
  • CTXR $2.85
  • ICCH $23.35
  • Average True Range (ATR)
  • CTXR 0.34
  • ICCH 0.07
  • MACD
  • CTXR 0.15
  • ICCH 0.02
  • Stochastic Oscillator
  • CTXR 24.99
  • ICCH 92.50

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

About ICCH ICC Holdings Inc.

ICC Holdings Inc is a specialty insurance carrier underwriting commercial multi-peril, liquor liability, worker's compensation, and umbrella liability coverages for the food and beverage industry. The company markets its products through a network of independent agents in Colorado, Illinois, Indiana, Iowa, Kansas, Minnesota, Missouri, Pennsylvania, Ohio, and Wisconsin.

Share on Social Networks: